News
-
-
-
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech's Universal Registration Document 2024 with business development and financial statements is now available. Learn about the leading biopharmaceutical company's global presence and innovative solutions -
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 9th Interim Report
Alzchem Group AG published its 9th Interim Report, revealing the acquisition of 8,730 shares as part of the share buyback program. Detailed information available on the company's website -
-
